Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CAFs shape myeloid‐derived suppressor cells to promote stemness of intrahepatic cholangiocarcinoma through 5‐lipoxygenase
Yuli Lin, Qian Cai, Yu Chen, et al.
Hepatology (2021) Vol. 75, Iss. 1, pp. 28-42
Closed Access | Times Cited: 119

Showing 51-75 of 119 citing articles:

Hepatocellular carcinoma progression promoted by 5-lipoxygenase activity in CD163(+) tumor-associated macrophages
Takuto Nosaka, Y. Murata, Kazuto Takahashi, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114592-114592
Open Access | Times Cited: 10
Myeloid-derived suppressor cells: key immunosuppressive regulators and therapeutic targets in cancer
Lingfei Li, Mingyang Li, Qingge Jia
Pathology - Research and Practice (2023) Vol. 248, pp. 154711-154711
Closed Access | Times Cited: 10
DDX18 drives tumor immune escape through transcription-activated STAT1 expression in pancreatic cancer
Guoying Dong, Qin Wang, Mingxin Wen, et al.
Oncogene (2023) Vol. 42, Iss. 40, pp. 3000-3014
Closed Access | Times Cited: 10
Identification of CREB5 as a prognostic and immunotherapeutic biomarker in glioma through multi-omics pan-cancer analysis
Zhixuan Wu, Xiaowu Wang, Haodong Wu, et al.
Computers in Biology and Medicine (2024) Vol. 173, pp. 108307-108307
Closed Access | Times Cited: 3
MDACT: A New Principle of Adjunctive Cancer Treatment Using Combinations of Multiple Repurposed Drugs, with an Example Regimen
Richard E. Kast, Alex Alfieri, Hazem Assi, et al.
Cancers (2022) Vol. 14, Iss. 10, pp. 2563-2563
Open Access | Times Cited: 14
Cancer-associated fibroblasts: Just on the opposite side of antitumour immunity?
Shuaiqingying Guo, Jing Yuan, Xiaolin Meng, et al.
International Immunopharmacology (2023) Vol. 122, pp. 110601-110601
Open Access | Times Cited: 8
Oncogenic PIK3CA recruits myeloid‐derived suppressor cells to shape the immunosuppressive tumour microenvironment in luminal breast cancer through the 5‐lipoxygenase‐dependent arachidonic acid pathway
Xingchen Li, Guidong Chen, Fanchen Wang, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 11
Open Access | Times Cited: 8
TP53I13 promotes metastasis in glioma via macrophages, neutrophils, and fibroblasts and is a potential prognostic biomarker
Xinqi Ge, Manyu Xu, Tong Cheng, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 13
Tumor immune microenvironment and the current immunotherapy of cholangiocarcinoma (Review)
Siqi Yang, Rui-Qi Zou, Yu-Shi Dai, et al.
International Journal of Oncology (2023) Vol. 63, Iss. 6
Open Access | Times Cited: 7
Heterogeneity and interplay: the multifaceted role of cancer-associated fibroblasts in the tumor and therapeutic strategies
Qiaoqiao Liu, Fei Yao, Liangliang Wu, et al.
Clinical & Translational Oncology (2024) Vol. 26, Iss. 10, pp. 2395-2417
Closed Access | Times Cited: 2
Single-cell analysis defines LGALS1 + fibroblasts that promote proliferation and migration of intrahepatic cholangiocarcinoma
Qiqi Cao, Jinxian Yang, Lixuan Jiang, et al.
Journal of Molecular Cell Biology (2024)
Open Access | Times Cited: 2
Nanoquercetin based nanoformulations for triple negative breast cancer therapy and its role in overcoming drug resistance
Adyasa Samantaray, Debasish Pradhan, N Nayak, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Metabolic and Immunological Implications of MME+CAF-Mediated Hypoxia Signaling in Pancreatic Cancer Progression: Therapeutic Insights and Translational Opportunities
Bin Wang, Yue Pan, Yongjie Xie, et al.
Biological Procedures Online (2024) Vol. 26, Iss. 1
Open Access | Times Cited: 2
Tumor Immune Microenvironment in Intrahepatic Cholangiocarcinoma: Regulatory Mechanisms, Functions, and Therapeutic Implications
Angela Dalia Ricci, Alessandro Rizzo, Annalisa Schirizzi, et al.
Cancers (2024) Vol. 16, Iss. 20, pp. 3542-3542
Open Access | Times Cited: 2
Cancer‐associated fibroblasts promote tumor cell growth via miR‐493‐5p in intrahepatic cholangiocarcinoma
Katsuya Toshida, Shinji Itoh, Noboru Harada, et al.
Cancer Science (2022) Vol. 114, Iss. 3, pp. 937-947
Open Access | Times Cited: 12
MDSCs might be “Achilles heel” for eradicating CSCs
Tao Yang, Ning Liang, Jing Li, et al.
Cytokine & Growth Factor Reviews (2022) Vol. 65, pp. 39-50
Closed Access | Times Cited: 11
Cancer-associated fibroblasts as accomplices to confer therapeutic resistance in cancer
Wenyu Wang, Bing Cheng, Qiang Yu
Cancer Drug Resistance (2022) Vol. 5, pp. 889-901
Open Access | Times Cited: 11
Cancer‐associated fibroblasts nurture LGR5 marked liver tumor‐initiating cells and promote their tumor formation, growth, and metastasis
Mingna Zhang, Yiqiao Fang, Xia Fu, et al.
Cancer Medicine (2023) Vol. 12, Iss. 17, pp. 18032-18049
Open Access | Times Cited: 6
An Exosome-Related Long Non-coding RNA (lncRNA)-Based Signature for Prognosis and Therapeutic Interventions in Lung Adenocarcinoma
Jinhong Li, Junhua Wang, Zhihong Chen, et al.
Cureus (2023)
Open Access | Times Cited: 6
Loss of α-1,2-mannosidase MAN1C1 promotes tumorigenesis of intrahepatic cholangiocarcinoma through enhancing CD133-FIP200 interaction
Yuanyan Wei, Qihang Chen, Jiayue Chen, et al.
Cell Reports (2023) Vol. 42, Iss. 12, pp. 113588-113588
Open Access | Times Cited: 6
NT5E upregulation in head and neck squamous cell carcinoma: A novel biomarker on cancer-associated fibroblasts for predicting immunosuppressive tumor microenvironment
Xuemin Chen, Yuyang Liu, Bing-yan Tao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Selecting an Appropriate Experimental Animal Model for Cholangiocarcinoma Research
Man Li, Xueli Zhou, Wei Wang, et al.
Journal of Clinical and Translational Hepatology (2022) Vol. 10, Iss. 4, pp. 700-710
Open Access | Times Cited: 9
MMP14 is a diagnostic gene of intrahepatic cholangiocarcinoma associated with immune cell infiltration
Jun Wu, Yang Guo, Zhifan Zuo, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 19, pp. 2961-2978
Open Access | Times Cited: 5
Biophysical heterogeneity of myeloid-derived microenvironment to regulate resistance to cancer immunotherapy
Jie Zhao, Yiting Dong, Yundi Zhang, et al.
Advanced Drug Delivery Reviews (2022) Vol. 191, pp. 114585-114585
Open Access | Times Cited: 8
Reciprocal Relationship Between Cancer Stem Cells and Myeloid-Derived Suppressor Cells: Implications for Tumor Progression and Therapeutic Strategies
Guiqing Ding, Hua Yu, Jason Gang Jin, et al.
Future Oncology (2024) Vol. 20, Iss. 4, pp. 215-228
Closed Access | Times Cited: 1

Scroll to top